Wegovy and Zepbound are 2 FDA-approved injectables for weight loss. Learn how they compare in benefits, side effects, and ...

Lower prices for 15 drugs, including Ozempic and Wegovy, are expected to be announced by the end of the month. The price ...

The White House is in discussions with the makers of weight loss drugs Wegovy and Zepbound to drastically lower prices, NBC ...

President Donald Trump announced that his administration has finally struck a deal with Novo Nordisk and Eli Lilly to reduce ...

Trump launches "TrumpRx" program to cut prices of Wegovy and Zepbound, making weight-loss drugs more affordable for Americans ...

The Trump administration is currently negotiating with Danish pharmaceuticals, including Eli Lilly and Novo Nordisk to ...

Zepbound (tirzepatide) and Wegovy (semaglutide) are FDA-approved injectable medications revolutionizing weight management. Both belong to the incretin mimetic drug class but differ in their mechanisms ...

Drugmaker Eli Lilly said it would soon start late-stage trials for eloralintide, a drug mimicking the pancreatic hormone ...

Wegovy Zepbound cost-effectiveness report finds both drugs remain valuable at higher prices despite affordability concerns, per ICER analysis.

Eli Lilly (LLY) drops CVS Health's (CVS) drug plan after the health insurer limited access to its obesity drug, Zepbound in favor of Novo's (NVO) Wegovy. Read more here.